Atripla (efavirenz/emtricitabine/tenofovir disoproxil fumarate)

Many patients pay $0 through manufacturer patient assistance programs. Contact our pharmacists — we handle all the paperwork.

Atripla was one of the first single-tablet regimens for HIV-1 treatment, combining efavirenz, emtricitabine, and tenofovir disoproxil fumarate. It is taken once daily on an empty stomach, preferably at bedtime to help manage CNS side effects.

Atripla remains an option for virologically stable patients and is widely available with generic alternatives that can reduce cost significantly.

• Once-daily single tablet
• Generic versions available for cost savings
• Bedtime dosing to minimize side effects
• Long-established efficacy record